Giant Cell Arteritis Workup
Immediate Laboratory Testing Required
This patient requires immediate ESR and CRP measurement followed by urgent high-dose corticosteroid initiation without waiting for results, as the combination of severe retro-orbital headache and temporal artery pain in a 60-year-old man represents giant cell arteritis (GCA) until proven otherwise. 1
Essential Immediate Labs
- Draw ESR and CRP immediately before any other testing, as ESR >50 mm/h has 78.9% sensitivity for GCA and CRP elevation has 79.2% sensitivity 1
- Do not delay treatment while awaiting these results—the priority is preventing irreversible bilateral blindness 1, 2
- ESR >60 mm/h significantly upgrades suspicion for GCA, and ESR >100 mm/h has 92.2% specificity with a positive likelihood ratio of 3.11 1, 3
Critical Clinical Assessment Details
Beyond the temporal artery tenderness already noted, specifically assess for:
- Jaw claudication (pain with chewing)—this is pathognomonic for GCA with a positive likelihood ratio of 4.90 and present in approximately 50% of cases 1, 4
- Visual symptoms including transient vision loss, diplopia, or any acute vision changes—these indicate ischemic optic neuropathy representing an ophthalmologic emergency 5, 1
- Constitutional symptoms including low-grade fever, weight loss, malaise, and proximal myalgia (polymyalgia rheumatica symptoms) 5, 1, 4
- Scalp tenderness beyond the temporal area, which has 38.9% sensitivity and 78.9% specificity for GCA 1
Immediate Management Algorithm
Step 1: Initiate Corticosteroids Immediately
- Start prednisone 40-60 mg daily immediately upon clinical suspicion, even before laboratory confirmation 1, 2, 4
- This is the single most important intervention to prevent permanent bilateral blindness 1
- Delaying corticosteroids while awaiting ESR/CRP results or temporal artery biopsy is the most common and dangerous error 1, 2
Step 2: Arrange Temporal Artery Biopsy
- Schedule temporal artery biopsy urgently (ideally within 1-2 weeks), but do not delay treatment 1, 2, 4
- The biopsy remains diagnostic for up to 2 weeks after corticosteroid initiation without affecting diagnostic yield 1, 2, 4
- Temporal artery biopsy is the gold standard with 67-97% sensitivity 1, 6
Step 3: Ophthalmology Referral
- Obtain same-day or next-day ophthalmology consultation to assess for visual symptoms or subclinical involvement 2
- This facilitates temporal artery biopsy planning and ongoing management 1
Step 4: Stroke Center Referral if Indicated
- If there are any visual symptoms suggesting retinal or ophthalmic artery occlusion, refer immediately to the nearest stroke center for neurological evaluation 5
- Up to 24% of patients with central retinal artery occlusion have concurrent cerebrovascular accident on diffusion-weighted MRI 5
Additional Diagnostic Considerations
Complete Blood Count
ANCA Testing in Atypical Cases
- If the patient has atypical manifestations (ear/nose/throat involvement, renal/pulmonary/neurologic symptoms), is refractory to glucocorticoid treatment, or experiences early relapse, consider ANCA testing 7
- ANCA-associated vasculitides can present with temporal arteritis in 66% of cases with atypical GCA features 7
- Patients with temporal arteritis revealing AAV are younger (median age 70 vs 74 years), more frequently male, and have higher CRP levels 7
Imaging for Large Vessel Involvement
- Consider PET/CT or vascular imaging to identify extracranial large vessel involvement, as 86% of GCA patients show uptake consistent with large vessel vasculitis 2, 8
- Check peripheral pulses and blood pressure in both arms 2
Critical Pitfalls to Avoid
- Never delay corticosteroids while awaiting ESR/CRP results or temporal artery biopsy in suspected GCA with headache and temporal artery tenderness 1, 2
- Do not attribute symptoms to migraine in a 60-year-old with new-onset headache—new-onset persistent localized headache after age 50 warrants GCA evaluation 1
- Do not pursue neuroimaging first when GCA is suspected based on classic symptoms (the CT already performed showing only microangiopathic changes does not exclude GCA) 1
- Do not wait for biopsy confirmation before starting treatment—vision loss is irreversible once established 1, 2, 6
- Approximately 11% of GCA patients have normal inflammatory markers, so clinical suspicion overrides laboratory values 1
Monitoring Strategy
- Monitor ESR and CRP every 2-4 weeks initially until normalization, then every 6 months during maintenance therapy 1, 2
- Most patients require 2-3 years of treatment with gradual tapering guided by clinical symptoms and inflammatory markers 2, 4
- 34-62% of patients experience flares during taper, requiring close monitoring 1